News

Find News

Filter articles

Showing 3041 to 3050 of 3417 results

Cipla agrees Rifaximin licensing deal

International19-09-2014

Indian drug maker Cipla has signed a deal with Salix Pharmaceuticals allowing the US-based company exclusive rights relating to the Rifaximin Complexes patent family.

Gilead announces Sovaldi generic deal

India, US17-09-2014

US biotechnology company Gilead has agreed a licensing deal with seven Indian drug makers that will enable them to sell a generic version of a drug used to treat hepatitis C.

Epirus, Ranbaxy win Indian approval for arthritis drug

India16-09-2014

Biopharmaceutical company Epirus has said that India’s drug regulator has approved a biosimilar application to produce a version of a popular arthritis treatment drug.

Pharmaceutical IP under threat from malware, says report

International15-09-2014

A newly revealed malware could be looking to attack the pharmaceutical sector in order to steal IP, a report has claimed.

Kilpatrick Townsend adds Life sciences specialist to team

US12-09-2014

Law firm Kilpatrick Townsend & Stockton LLP has bolstered its Californian team with the appointment of a new pharmaceutical IP specialist.

Carpmaels & Ransford hires two new partners to its London office

UK11-09-2014

UK-based law firm Carpmaels & Ransford LLP has announced the appointment of two new partners to its London office.

Bristol-Myers Squibb hits Merck with cancer patent lawsuit

US10-09-2014

Bristol-Myers Squibb has accused pharmaceutical company Merck of infringing a patent covering a method used to treat cancer.

Australia suggests uprooting plant rights committee

Australia09-09-2014

The Australian government department responsible for IP has suggested abolishing a committee that looks after plant breeders’ rights as it looks at alternative means for giving advice to breeders.

Myriad cancer patent upheld in Australia

Australia08-09-2014

Companies in Australia will be able to continue to patent human genes after a court rejected an appeal by a breast cancer survivor.

Magistrate judge recommends action in Section 101 case

US05-09-2014Legal developments

Magistrate judge Christopher Burke has recommended that the US District Court for the District of Delaware affirm a motion to dismiss a patent infringement case related to the patent eligibility of subject matter, as laid out in 35 USC §101.

Showing 3041 to 3050 of 3417 results

LSIPR